292 related articles for article (PubMed ID: 30146478)
1. Combinatorial CRISPR/Cas9 Approach to Elucidate a Far-Upstream Enhancer Complex for Tissue-Specific Sox9 Expression.
Mochizuki Y; Chiba T; Kataoka K; Yamashita S; Sato T; Kato T; Takahashi K; Miyamoto T; Kitazawa M; Hatta T; Natsume T; Takai S; Asahara H
Dev Cell; 2018 Sep; 46(6):794-806.e6. PubMed ID: 30146478
[TBL] [Abstract][Full Text] [Related]
2. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
Han Y; Lefebvre V
Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
[TBL] [Abstract][Full Text] [Related]
3. The SOX9 upstream region prone to chromosomal aberrations causing campomelic dysplasia contains multiple cartilage enhancers.
Yao B; Wang Q; Liu CF; Bhattaram P; Li W; Mead TJ; Crish JF; Lefebvre V
Nucleic Acids Res; 2015 Jun; 43(11):5394-408. PubMed ID: 25940622
[TBL] [Abstract][Full Text] [Related]
4. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
5. SOX9cre1, a cis-acting regulatory element located 1.1 Mb upstream of SOX9, mediates its enhancement through the SHH pathway.
Bien-Willner GA; Stankiewicz P; Lupski JR
Hum Mol Genet; 2007 May; 16(10):1143-56. PubMed ID: 17409199
[TBL] [Abstract][Full Text] [Related]
6. miR-1247 functions by targeting cartilage transcription factor SOX9.
Martinez-Sanchez A; Murphy CL
J Biol Chem; 2013 Oct; 288(43):30802-14. PubMed ID: 24014021
[TBL] [Abstract][Full Text] [Related]
7. Variability in a three-generation family with Pierre Robin sequence, acampomelic campomelic dysplasia, and intellectual disability due to a novel ∼1 Mb deletion upstream of SOX9, and including KCNJ2 and KCNJ16.
Castori M; Bottillo I; Morlino S; Barone C; Cascone P; ; Grammatico P; Laino L
Birth Defects Res A Clin Mol Teratol; 2016 Jan; 106(1):61-8. PubMed ID: 26663529
[TBL] [Abstract][Full Text] [Related]
8. The clinical impact of chromosomal rearrangements with breakpoints upstream of the SOX9 gene: two novel de novo balanced translocations associated with acampomelic campomelic dysplasia.
Fonseca AC; Bonaldi A; Bertola DR; Kim CA; Otto PA; Vianna-Morgante AM
BMC Med Genet; 2013 May; 14():50. PubMed ID: 23648064
[TBL] [Abstract][Full Text] [Related]
9. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression.
Leung VY; Gao B; Leung KK; Melhado IG; Wynn SL; Au TY; Dung NW; Lau JY; Mak AC; Chan D; Cheah KS
PLoS Genet; 2011 Nov; 7(11):e1002356. PubMed ID: 22072985
[TBL] [Abstract][Full Text] [Related]
10. Hmgb1 can facilitate activation of the matrilin-1 gene promoter by Sox9 and L-Sox5/Sox6 in early steps of chondrogenesis.
Szénási T; Kénesi E; Nagy A; Molnár A; Bálint BL; Zvara Á; Csabai Z; Deák F; Boros Oláh B; Mátés L; Nagy L; Puskás LG; Kiss I
Biochim Biophys Acta; 2013 Oct; 1829(10):1075-91. PubMed ID: 23860260
[TBL] [Abstract][Full Text] [Related]
11. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
[TBL] [Abstract][Full Text] [Related]
12. SOX9 chromatin folding domains correlate with its real and putative distant cis-regulatory elements.
Smyk M; Akdemir KC; Stankiewicz P
Nucleus; 2017 Mar; 8(2):182-187. PubMed ID: 28085555
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative SOX9 mutations in campomelic dysplasia.
Csukasi F; Duran I; Zhang W; Martin JH; Barad M; Bamshad M; Weis MA; Eyre D; Krakow D; Cohn DH
Hum Mutat; 2019 Dec; 40(12):2344-2352. PubMed ID: 31389106
[TBL] [Abstract][Full Text] [Related]
14. Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes.
Hall MD; Murray CA; Valdez MJ; Perantoni AO
PLoS Genet; 2017 Feb; 13(2):e1006610. PubMed ID: 28166224
[TBL] [Abstract][Full Text] [Related]
15. Familial acampomelic form of campomelic dysplasia caused by a 960 kb deletion upstream of SOX9.
Lecointre C; Pichon O; Hamel A; Heloury Y; Michel-Calemard L; Morel Y; David A; Le Caignec C
Am J Med Genet A; 2009 Jun; 149A(6):1183-9. PubMed ID: 19449405
[TBL] [Abstract][Full Text] [Related]
16. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
Wenke AK; Grässel S; Moser M; Bosserhoff AK
FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
[TBL] [Abstract][Full Text] [Related]
17. Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
Huang BL; Brugger SM; Lyons KM
J Biol Chem; 2010 Sep; 285(36):27702-12. PubMed ID: 20571031
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel craniofacial regulatory domains located far upstream of SOX9 and disrupted in Pierre Robin sequence.
Gordon CT; Attanasio C; Bhatia S; Benko S; Ansari M; Tan TY; Munnich A; Pennacchio LA; Abadie V; Temple IK; Goldenberg A; van Heyningen V; Amiel J; FitzPatrick D; Kleinjan DA; Visel A; Lyonnet S
Hum Mutat; 2014 Aug; 35(8):1011-20. PubMed ID: 24934569
[TBL] [Abstract][Full Text] [Related]
19. A de novo 1.58 Mb deletion, including MAP2K6 and mapping 1.28 Mb upstream to SOX9, identified in a patient with Pierre Robin sequence and osteopenia with multiple fractures.
Smyk M; Roeder E; Cheung SW; Szafranski P; Stankiewicz P
Am J Med Genet A; 2015 Aug; 167A(8):1842-50. PubMed ID: 26059046
[TBL] [Abstract][Full Text] [Related]
20. ZNF606 interacts with Sox9 to regulate chondrocyte differentiation.
Zhou Z; Yu H; Wang Y; Guo Q; Wang L; Zhang H
Biochem Biophys Res Commun; 2016 Oct; 479(4):920-926. PubMed ID: 27634221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
